Ex-Sanofi CEO helps launch Boston Pharmaceuticals with $600M
Boston Pharmaceuticals will focus on developing drugs that are already clinic-ready - outsourcing much of the clinical work to CROs and bringing novel drugs to late stage trials or commercialization.